Antimicrobial peptide delivery: an emerging therapeutic for the treatment of burn and wounds.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Therapeutic delivery

• Publication date

  2018-04-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.4155/tde-2017-0061PMID 29681237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nanoemulsion is an effective antimicrobial for methicillin-resistant Staphylococcus aureus in infected wounds.

  2017cited by this paper
• Nanoemulsion Therapy for Burn Wounds Is Effective as a Topical Antimicrobial Against Gram-Negative and Gram-Positive Bacteria

  2016cited by this paper
• The Burn Wound Microenvironment

  2016cited by this paper
• Models of In-Vivo Bacterial Infections for the Development of Antimicrobial Peptide-based Drugs.

  2016cited by this paper
• Rational Evolution of Antimicrobial Peptides Containing Unnatural Amino Acids to Combat Burn Wound Infections

  2016cited by this paper
• LL37 loaded nanostructured lipid carriers (NLC): A new strategy for the topical treatment of chronic wounds.

  2016cited by this paper
• APD3: the antimicrobial peptide database as a tool for research and education

  2015cited by this paper
• Improved burn wound healing by the antimicrobial peptide LLKKK18 released from conjugates with dextrin embedded in a carbopol gel.

  2015cited by this paper
• CAMPR3: a database on sequences, structures and signatures of antimicrobial peptides

  2015cited by this paper
• Efficacy and safety profile of the novel antimicrobial peptide PXL150 in a mouse model of infected burn wounds.

  2015cited by this paper
• Polyvinyl alcohol nanofiber formulation of the designer antimicrobial peptide APO sterilizes Acinetobacter baumannii-infected skin wounds in mice

  2015cited by this paper
• Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis

  2015cited by this paper
• Role of Nanotechnology in Delivery of Protein and Peptide Drugs.

  2015cited by this paper
• Therapeutic utility of antibacterial peptides in wound healing

  2015cited by this paper
• Wound dressings – a review

  2015cited by this paper
• PLGA nanoparticles loaded with host defense peptide LL37 promote wound healing.

  2014cited by this paper
• LL-37-Derived Peptides Eradicate Multidrug-Resistant Staphylococcus aureus from Thermally Wounded Human Skin Equivalents

  2014cited by this paper
• Efficacy of the designer antimicrobial peptide SHAP1 in wound healing and wound infection

  2014cited by this paper
• A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: In vitro bioactivity and in vivo effectiveness in healing-impaired db/db mice.

  2014cited by this paper
• Engineered Cationic Antimicrobial Peptides To Overcome Multidrug Resistance by ESKAPE Pathogens

  2014cited by this paper
• Rapid systemic and local treatments with the antibacterial peptide dimer A3-APO and its monomeric metabolite eliminate bacteria and reduce inflammation in intradermal lesions infected with Propionibacterium acnes and meticillin-resistant Staphylococcus aureus.

  2013cited by this paper
• Curbing Inflammation in Burn Patients

  2013cited by this paper
• Cationic Antimicrobial Peptides

  2012cited by this paper
• Biphasic vesicles for topical delivery of interferon alpha in human volunteers and treatment of patients with human papillomavirus infections.

  2011cited by this paper
• Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved.

  2011cited by this paper
• Designing carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide.

  2011cited by this paper
• Chronic wounds and the medical biofilm paradigm.

  2010cited by this paper
• Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections.

  2010cited by this paper
• Topical antimicrobials for burn wound infections.

  2010cited by this paper
• The biology of burn injury

  2010cited by this paper
• A Review of the Local Pathophysiologic Bases of Burn Wound Progression

  2010cited by this paper
• Evaluation of Silver Nanoparticle Toxicity in Skin in Vivo and Keratinocytes in Vitro

  2009cited by this paper
• Adaptation of the bacterial membrane to changing environments using aminoacylated phospholipids

  2009cited by this paper
• Antimicrobial peptide delivery from degradable polymer thin films

  2009cited by this paper
• A review of the applications of the hydrofiber dressing with silver (Aquacel Ag®) in wound care

  2009cited by this paper
• Enhancement effect of terpenes on silver sulphadiazine permeation through third-degree burn eschar.

  2009cited by this paper
• Immune evasion: Overcoming defensins

  2008cited by this paper
• Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression

  2008cited by this paper
• Biofilms in chronic wounds

  2008cited by this paper
• Enhancing drugs absorption through third-degree burn wound eschar.

  2008cited by this paper
• American Burn Association Consensus Conference to Define Sepsis and Infection in Burns

  2007cited by this paper
• The Human Host Defense Peptide LL37/hCAP Accelerates Angiogenesis in PEGT/PBT Biopolymers

  2006cited by this paper
• The co-evolution of host cationic antimicrobial peptides and microbial resistance

  2006cited by this paper
• Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

  2006cited by this paper
• Side‐chain entropy effects on protein secondary structure formation

  2005cited by this paper
• The silver‐releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial

  2005cited by this paper
• Multivesicular liposomes for oral delivery of recombinant human epidermal growth factor

  2005cited by this paper
• Immunofluorescence Deconvolution Microscopy and Image Reconstruction of Human Defensins in Normal and Burned Skin

  2005cited by this paper
• The role of pericytes in blood-vessel formation and maintenance.

  2005cited by this paper
• Systemic Responses to Burn Injury

  2004cited by this paper
• The clinical relevance of microbiology in acute and chronic wounds.

  2003cited by this paper
• Mechanisms of Antimicrobial Peptide Action and Resistance

  2003cited by this paper
• Slow release iodine preparation and wound healing: in vitro effects consistent with lack of in vivo toxicity in human chronic wounds

  2002cited by this paper
• Wound pathophysiology, infection and therapeutic options

  2002cited by this paper
• The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses1

  2002cited by this paper
• Activity of Novispirin G10 against Pseudomonas aeruginosa In Vitro and in Infected Burns

  2002cited by this paper
• Silver. I: Its antibacterial properties and mechanism of action.

  2002cited by this paper
• Mode of action of membrane active antimicrobial peptides.

  2002cited by this paper
• Wound Microbiology and Associated Approaches to Wound Management

  2001cited by this paper
• Antimicrobial Peptides: Properties and Applicability

  2001cited by this paper
• Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of Gram-negative bacteria

  2001cited by this paper
• Liposome associated interferon-alpha-2b functions as an anti-fibrogenic factor in dermal wounds in the guinea pig

  2000cited by this paper
• A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver.

  2000cited by this paper
• Biology of wound healing.

  2000cited by this paper
• Diversity of antimicrobial peptides and their mechanisms of action.

  1999cited by this paper
• In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers.

  1999cited by this paper
• The proteolytic environment of chronic wounds

  1999cited by this paper
• Cutaneous wound healing.

  1999cited by this paper
• Mode of action of linear amphipathic α-helical antimicrobial peptides

  1998cited by this paper
• Mode of action of linear amphipathic alpha-helical antimicrobial peptides.

  1998cited by this paper
• Povidone-iodine liposomes--an overview.

  1997cited by this paper
• Origins and Evolution of Antibiotic Resistance

  1996cited by this paper
• Antimicrobial activity of a 13 amino acid tryptophan‐rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides

  1996cited by this paper
• Microbial biofilms.

  1995cited by this paper
• Secondary structure and membrane interaction of PR-39, a Pro+Arg-rich antibacterial peptide.

  1994cited by this paper
• Definitions and guidelines for assessment of wounds and evaluation of healing.

  1994cited by this paper
• Dermal Absorption of Peptides and Proteins

  1993cited by this paper
• The skin immune system: progress in cutaneous biology.

  1993cited by this paper
• Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes.

  1992cited by this paper
• Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils.

  1992cited by this paper
• Wound infection under occlusive dressings.

  1991cited by this paper
• Burn shock.

  1990cited by this paper
• Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.

  1988cited by this paper
• Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping.

  1988cited by this paper
• Burn wound dressings--a review.

  1987cited by this paper
• Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor

  1987cited by this paper
• Topical antimicrobial toxicity.

  1985cited by this paper
• The cause of venous ulceration.

  1982cited by this paper
• In Vitro Penetration of Topical Antiseptics Through Eschar of Burn Patients

  1976cited by this paper
• THE RULE OF NINES: ITS HISTORY AND ACCURACY

  1968cited by this paper
• TREATMENT OF LARGE HUMAN BURNS WITH 0.5 PER CENT SILVER NITRATE SOLUTION.

  1965cited by this paper
• Treatment of Large Human Burns With 0.5% Silver Nitrate Solution

  1965cited by this paper

• Antimicrobial peptide chensinin-1b attenuates T2DM progression in atherosclerotic ApoE-/- mice.

  2026cites this paper
• From stem cells to skin: ADSCP6 peptide's role in transforming scar therapy.

  2025cites this paper
• Chensinin-1b Alleviates DSS-Induced Inflammatory Bowel Disease by Inducing Macrophage Switching from the M1 to the M2 Phenotype

  2024cites this paper
• Dynamics of blood serum biochemical parameters in the treatment of purulent wounds in dogs

  2024cites this paper
• Combining functionalities-nanoarchitectonics for combatting bacterial infection.

  2024cites this paper
• Rapid Membrane-Penetrating Hybrid Peptides Achieve Efficient Dual Antimicrobial and Antibiofilm Activity through a Triple Bactericidal Mechanism

  2024cites this paper
• Advances of Antimicrobial Peptide‐Based Biomaterials for the Treatment of Bacterial Infections

  2023cites this paper
• Editorial: Biological macromolecules from marine organisms: isolation, characterization and pharmacological activities

  2023cites this paper
• Skin and wound delivery systems for antimicrobial peptides

  2023influential citation
• Bioinformatics-led identification of potential biomarkers and inflammatory infiltrates in burn injury.

  2023cites this paper
• Antimicrobial peptides from marine animals: Sources, structures, mechanisms and the potential for drug development

  2023cites this paper
• Pharmaceutical nanotechnology: Antimicrobial peptides as potential new drugs against WHO list of critical, high, and medium priority bacteria.

  2022cites this paper
• Atomic-Resolution Structures and Mode of Action of Clinically Relevant Antimicrobial Peptides

  2022cites this paper
• Design and pharmacodynamic evaluation of DPK-060 loaded Nanostructured lipid carrier embedded gel for dermal delivery: A novel approach in the treatment of atopic dermatitis.

  2022cites this paper
• Liposomes encapsulating novel antimicrobial peptide Omiganan: characterization and its pharmacodynamic evaluation in atopic dermatitis and psoriasis mice model.

  2022cites this paper
• Redução da toxicidade de antibacterianos através de carreadores nanoestruturados

  2022cites this paper
• Formulation Development of Topical Preparation Containing Nanoparticles of Povidone-Iodine for Wound Healing

  2021cites this paper
• Alternative Therapeutic Interventions: Antimicrobial Peptides and Small Molecules to Treat Microbial Keratitis

  2021cites this paper
• Therapeutic Effect of Darkling Beetle (Zophobas morio) Hemolymph on Skin Thermal Injury in Mice Infected by Staphylococcus haemolyticus

  2021cites this paper
• Nisin loaded carbopol gel against Pseudomonas aeruginosa infected third‐degree burns: A therapeutic intervention

  2021cites this paper
• Amphibian-derived peptide homodimer promotes regeneration of skin wounds.

  2021cites this paper
• Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response

  2020cites this paper
• Novel Therapeutics for the Treatment of Burn Infection

  2020cites this paper
• Antimicrobial peptides: a promising strategy for lung cancer drug discovery?

  2020cites this paper
• Human Antimicrobial Peptides: Spectrum, Mode of Action and Resistance Mechanisms

  2020cites this paper
• Oral Gene Delivery: An Innovative Approach for Colorectal Center Therapy

  2020cites this paper
• Human Antimicrobial Peptides: Spectrum, Mode of Action and Resistance Mechanisms

  2020cites this paper
• A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides

  2020cites this paper
• Liposomal Formulations In Cancer Therapy: Passive Versus Active Targeting

  2019cites this paper
• Mini Review on Antimicrobial Peptides, Sources, Mechanism and Recent Applications

  2019cites this paper